How do I set up a sample management platform for chain of custody and controlled user permissions in a pharma lab?

Setting up a sample management platform for chain of custody and controlled user permissions in a pharma lab is mostly about defining the right workflow, controls, and auditability before picking software. Here’s a practical way to approach it.

1) Define the sample lifecycle

Map every step a sample can take, for example:

• Sample creation / receipt
• Accessioning / registration
• Aliquoting / pooling
• Storage assignment
• Retrieval
• Testing / transfer
• Return / disposal / archival

For each step, define:

• Who is allowed to perform it
• What data must be captured
• What approvals are required
• What events must be logged

2) Establish chain-of-custody requirements

A strong chain of custody usually includes:

• Unique sample ID for every primary sample and derivative
• Time-stamped custody events
• User identity on every action
• Location tracking at container, rack, freezer, and room level
• Reason codes for transfers, disposals, and overrides
• Signature/confirmation for handoffs where needed
• Immutable audit trail with no silent edits

Best practice: each custody transfer should record:

• From user / department
• To user / department
• Date/time
• Sample ID(s)
• Location before and after
• Action reason
• Electronic signature or approval, if required

3) Design a role-based access model

Use role-based access control (RBAC) as the starting point.

Typical roles:

• Sample receiver / accessioner
• Lab analyst
• Storage manager
• QA reviewer
• System administrator
• Read-only auditor

Define permissions by role, such as:

• Create samples
• Edit metadata
• Move samples
• Split/aliquot samples
• Approve destruction
• View sensitive project data
• Export records
• Manage users/roles

In a pharma environment, consider adding attribute-based controls for things like:

• Project membership
• Site/location
• Sample classification
• Study phase
• GxP status
• Restricted materials

4) Build in segregation of duties

To reduce compliance risk, separate critical actions:

• The person who creates a sample should not be the only person who can approve disposal
• QA should review certain changes
• Admins should manage access, but not be able to alter scientific records without traceability

5) Choose a platform architecture

You can either:

• Buy a LIMS/ELN/sample management system with strong audit features, or
• Build a custom platform on top of a validated database/application stack

For pharma, make sure the platform supports:

• Audit trails
• Electronic signatures
• Record versioning
• Controlled access
• Data retention policies
• Validation documentation

Common integrations:

• LIMS / ELN
• ERP
• Instrument systems
• Barcode/RFID scanners
• Identity provider (Azure AD, Okta, LDAP, etc.)

6) Implement identity and access management

Use centralized authentication:

• SSO if possible
• MFA for privileged users
• Password policies aligned with corporate standards
• Automatic account disabling on termination or role change

For permissions:

• Default deny
• Least privilege
• Time-limited elevated access for special tasks
• Approval workflow for permission changes

7) Enforce barcode-based sample tracking

Barcoding is usually essential.

Good practice:

• Barcode every sample, aliquot, container, rack, and box
• Scan on every move
• Prevent manual ID entry except for exception handling
• Use location hierarchies:
  • Site > building > room > freezer > shelf > rack > box > position

This reduces errors and strengthens custody evidence.

8) Make audit trails tamper-evident

Audit logs should capture:

• User
• Timestamp
• Action
• Before/after values
• Reason for change
• Source IP/device if useful

Important:

• Do not allow deletion of audit events
• Keep audit logs separate from editable business records
• Restrict who can view sensitive logs

9) Put SOPs around system use

Technology alone isn’t enough. Create SOPs for:

• User onboarding/offboarding
• Sample receipt and labeling
• Transfers and handoffs
• Exceptions and discrepancies
• Data correction process
• Periodic access review
• Backup and recovery
• Incident reporting

Train users and document completion.

10) Validate the system for pharma use

If this is a regulated environment, validate according to applicable requirements, such as:

• 21 CFR Part 11 for electronic records/signatures
• EU Annex 11
• Internal GxP policies
• Data integrity principles: ALCOA+

Validation typically includes:

• User requirements specification
• Risk assessment
• Functional testing
• Security testing
• Audit trail verification
• Qualification of environment
• Change control process

11) Define reports and monitoring

Build reports for:

• Sample location and status
• Custody history
• Missing or overdue samples
• Access changes
• Unusual activity
• Expired retention items
• QA review exceptions

Set alerts for:

• Failed login attempts
• Unauthorized access attempts
• Transfers outside working hours
• Samples moved without proper approval

12) Roll out in phases

A good implementation path:

1. Map current process
2. Define roles and permissions
3. Configure sample hierarchy and metadata
4. Set up identity management and SSO
5. Enable barcode labels and scanners
6. Implement audit trail and approvals
7. Run pilot with one team or one sample type
8. Validate and train
9. Expand to full lab
10. Review metrics and refine

13) Ask these key questions before buying/building

• Does it support immutable audit trails?
• Can it handle hierarchical locations?
• Does it support electronic signatures?
• Can permissions be role-based and site-based?
• Can it integrate with SSO/MFA?
• Can it export records for audits?
• Does it support validation documentation?
• Can it handle aliquots, derivatives, and chain-of-custody events?

Recommended minimum controls

If you want a baseline setup, aim for:

• Unique sample IDs
• Barcode scanning
• RBAC with least privilege
• SSO + MFA
• Full audit trail
• Electronic signatures for key actions
• Location hierarchy
• Segregation of duties
• SOPs + training
• Regular access review
• Validation for regulated use

If you want, I can also provide:

1. a sample permission matrix,
2. a chain-of-custody workflow diagram, or
3. a vendor/build requirements checklist for pharma labs.